CoEBio3 News : CoEBio3 Winner of Chemicals Northwest Service Provider Award 2010

Click here to download CoEBio3 Report

CoEBio3 Winner of Chemicals Northwest Service Provider Award 2010

Posted on : 11 June 2010

Chemicals Northwest 2010 Awards

Service Provider Award, Sponsored by Business Link Northwest

"Presented to a company or organisation that excelled in providing a key service/support function to a chemical manufacturing site. The winning entry demonstrated how it had delivered value to its customers whilst enhancing its own business and reputation."

Paul Goddard, Commercial Director; Ian Rowles and Kirk Malone, Research Team Leaders, received the award on behalf of CoEBio3 image

Industrial biotechnology is a complex, multi-disciplinary and rapidly evolving area. As a result, sourcing specialist skills in IB can be costly and time-consuming even for well-resourced multinational organizations. CoEBio3 has established a single point of contact model whereby companies who wish to familiarize themselves with individual techniques or develop entire processes in industrial biotechnology can gain access to an extremely broad range of support and development services through one portal.

In 2007, CoEBio3 was approached by a multinational company who wished to develop technology in IB. Within four months of initial contact, CoEBio3 located and represented the individual capabilities of eleven separate technology providers in the UK (7 university depts and 4 private SME’s) and within another four months negotiated, compiled and concluded a multi million pound contract between the multinational company and four of these providers. Thereafter, CoEBio3 went on to manage the entire project to its successful conclusion and the complete satisfaction of the company concerned.

The portfolio of services that CoEBio3 offers includes the fundamental scientific disciplines of molecular biology, systems biology, enzymology and biocatalyst screening; biochemical engineering; access to scale-up/pilot plant facilities; industrial/academic training courses; trans-European networks in specialist areas such as glycobiology and project management. Furthermore, CoEBio3 prides itself not just on its quantative technological breadth, but also its qualitative commercial depth. Biotechnology is a notoriously expensive business and an informed understanding of the commercial viability, patentability and profitability of nascent processes is essential to success in the field.

View All News Items | View News Archive